このエントリーをはてなブックマークに追加
ID 57465
Author
Hishikawa, Tomohito Department of Neurological SurgeryOkayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID
Sugiu, Kenji Department of Neurological SurgeryOkayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID
Murai, Satoshi Department of Neurological SurgeryOkayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Takahashi, Yu Department of Neurological SurgeryOkayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kidani, Naoya Department of Neurological SurgeryOkayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Nishihiro, Shingo Department of Neurological SurgeryOkayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Hiramatsu, Masafumi Department of Neurological SurgeryOkayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Date, Isao Department of Neurological SurgeryOkayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID publons researchmap
Satow, Tetsu Department of NeurosurgeryNational Cerebral and Cardiovascular Center
Iihara, Koji Department of Neurosurgery Graduated School of Medical SciencesKyusyu University
Sakai, Nobuyuki Department of NeurosurgeryKobe City Medical Center General Hospital
JR-NET2 and JR-NET3 study groups.
Abstract
BACKGROUND:
The Japanese Registry of NeuroEndovascular Therapy 2 (JR-NET2) and 3 (JR-NET3) were nationwide surveys that evaluated clinical outcomes after neuroendovascular therapy in Japan. The aim of this study was to compare the prevalence and risk factors of complications of intracranial tumor embolization between JR-NET2 and JR-NET3.
METHODS:
A total of 1018 and 1545 consecutive patients with intracranial tumors treated with embolization were enrolled in JR-NET2 and JR-NET3, respectively. The prevalence of complications in intracranial tumor embolization and related risk factors were compared between JR-NET2 and JR-NET3.
RESULTS:
The prevalence of complications in JR-NET3 (3.69%) was significantly higher than that in JR-NET2 (1.48%) (p = 0.002). The multivariate analysis in JR-NET2 showed that embolization for tumors other than meningioma was the only significant risk factor for complication (odds ratio [OR], 3.88; 95% confidence interval [CI], 1.13-12.10; p = 0.032), and that in JR-NET3 revealed that embolization for feeders other than external carotid artery (ECA) (OR, 3.56; 95% CI, 2.03-6.25; p < 0.001) and use of liquid materials (OR, 2.65; 95% CI, 1.50-4.68; p < 0.001) were significant risks for complications. The frequency of embolization for feeders other than ECA in JR-NET3 (15.3%) was significantly higher than that in JR-NET2 (9.2%) (p < 0.001). Also, there was a significant difference in the frequency of use of liquid materials between JR-NET2 (21.2%) and JR-NET3 (41.2%) (p < 0.001).
CONCLUSIONS:
Embolization for feeders other than ECA and use of liquid materials could increase the complication rate in intracranial tumor embolization.
Keywords
Complication
Embolization
Intracranial tumor
Risk factors
Note
This fulltext will be available in Aug 2020
Published Date
2019-06-07
Publication Title
Acta Neurochirurgica
Volume
volume161
Issue
issue8
Publisher
Springer Nature
Start Page
1675
End Page
1682
ISSN
00016268
NCID
AA0050885X
Content Type
Journal Article
language
英語
OAI-PMH Set
岡山大学
File Version
author
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.1007/s00701-019-03970-w
Citation
Hishikawa, T., Sugiu, K., Murai, S. et al. Acta Neurochir (2019) 161: 1675. https://doi.org/10.1007/s00701-019-03970-w